Texas Equine Veterinary Association

3:30pm–4:20pm CEU: 1 THURSDAY, July 31 continued #101: CERVICAL VERTEBRAL STENOTIC MYELOPATHY DIAGNOSIS, MEDICAL AND SURGICAL MANAGEMENT 2:00pm–2:50pm CEU: 1 Granite Ballroom Snacks and Refreshments are available. Please take this time to visit with our sponsors. TRADESHOW OPENS, BREAK IN THE TRADESHOW 3:00pm–3:30pm #103 MEDICAL RECORDS: BEST PRACTICE TIPS STRAIGHT FROM THE HORSE'S MOUTH Travertine Room Speaker: Cynthia MacKenzie, DVM and Steven Golla, DVM An interactive session on best practices with medical records specifically utilizing the 3 T's: templates, technicians and technology and the most common complaints seen from equine practitioners. This talk will provide suggestions on how to maintain compliance with medical records and how to utilize available resources to best prepare against board complaints and lawsuits. An update on any new legislation or new rules that have developed will also be delivered. 22 #102: EQUINE PROTOZOAL MYELOENCEPHALITIS Tower Palm Pavilion Speaker: Steve Reed, DVM, DACVIM The accuracy of the examination is aided by use of diagnostic procedures such as radiography and myelography to determine if a horse has cervical vertebral stenotic myelopathy. The neuroanatomic localization will direct us to the cervical spinal cord and the standing radiographs of the cervical vertebral column will help determine if the spinal canal is narrow, however a myelogram or CAT scan or in the case of small horses or foals an MRI will be required to identify the exact location of compression. Horses with asymmetric ataxia, muscle atrophy, and neuroanatomical localization suggesting multifocal signs the examiner should suspect EPM. However to make an accurate diagnosis of this condition evaluation of antibodies in blood and CSF are helpful. Tower Palm Pavilion Speaker: Steve Reed, DVM, DACVIM Several challenges face veterinarians asked to diagnose, treat and establish a prognosis for horses with neurological diseases. The first is to perform a careful neurological examination and to localize the lesion. This is followed by testing to determine the cause of the neurological signs, development of a treatment plan, evaluation of the response to therapy and finally to determine if the horse is safe to return to athletic use.

• Cover